| · Email [email protected] Adress : Resitpasa Mahallesi, Eski Buyukdere Caddesi No:4 34467...

www.trpharmaexporters.org.tr | www.ieis.org.tr

Contact information:

+90 212 353 11 20 Fax: +90 212 353 11 41 [email protected]

Pharmaceutical Manufacturers Association of Turkey (IEIS)

Year of publication 2017

The industry exports to more than 150 countries largely to the European Union (EU), MENA and CIS countries.

Good Manufacturing Practices (GMP) have been in place since 1984 in Turkey and pharmaceutical companies are continuously being audited according to the stringent Ministry of Health (MoH) criteria.

The Turkish Pharmaceutical Industry

The Turkish pharmaceutical industry has a long-standing culture of production as well as a strong infrastructure.

The industry complies with today’s international standards in terms of its production technologies, capacity and qualified human resources. With its 68 production facilities, approxiamately 500 companies and 31,500 employees, our industry produces approximately 11,000 products.

68ProductionFacilities

12MultinationalCompanies

11Raw MaterialProduction Facilities

3MultinationalCompanies

Turkish Pharmaceutical Exporters Platform was established to promote the industry’s high standards and increase its competitiveness to make it a leading exporter in the global market. IEIS facilitates the functioning of and provides services to the Platform.

Platform’s main activities are as follows:• Developing policies and strategies to increase exports of the Turkish

pharmaceutical industry• Conducting studies to positively affect the perception towards the

pharmaceutical products produced in Turkey• Carrying out communication activities to promote Turkish pharmaceutical

industry• Organizing events and missions in target markets to promote the Turkish

pharmaceutical industry, participating in these organizations• Networking between the Platform members and foreign drug authorities to

facilitate certification of production plants and to overcome regulatory issues• Conducting research to determine strategies for target markets,• Sustaining a continuous dialogue with Turkish authorities to maintain their

strategic support to the Platform’s activities.• Sharing the cooperation requests coming from foreign companies with the

Platform members• Supporting incentives related to R&D studies to promote exports of the

pharmaceutical industry

Asia 53%

Europe 35%

America 7%

Africa 5%

Pharmaceutical Exports by Region (2016)

Turkish Pharmaceutical Exporters Platform

First 10 Export Markets

USIraq

IranSlovenia

LibyaTR Northern Cyprus

SwitzerlandGermany

AzerbaijanSouth Korea

The Turkish Pharmaceutical Industry

Abdi İbrahim Pharmaceuticals

Adeka Pharmaceuticals

Ali Raif Pharmaceuticals

Atabay Pharmaceuticals and Pharmaceutical Fine Chemicals

Berko Pharmaceuticals and Chemical Products

Biem Pharmaceuticals

Bilim Pharmaceuticals

Biofarma Pharmaceuticals

Birgi Mefar Group

Centurion Pharma

Dem Pharmaceuticals

Deva Holding

Drogsan Pharmaceuticals

Eczacıbaşı Monrol Nuclear Products Co.

Farma-Tek Pharmaceuticals

Pantone 285 C

PHARMACEUTICALS AND FINE CHEMICALS

İlko Pharmaceuticals

Keymen Pharmaceuticals

Kurtsan Pharmaceuticals

Nobel Pharmaceuticals

Oro Pharmaceuticals

Pharmactive

Polifarma Pharmaceuticals

Recordati Pharmaceuticals

Sandoz Syntek Active Pharmaceutical Ingredients

Sandoz Turkey

Sanovel Pharmaceuticals

Santa Farma Pharmaceuticals

Vem Pharmaceuticals

World Medicine Pharmaceuticals

Zentiva Healthcare Products

e em

Name : Position : Phone : Email : Adress :

Contact Person

Abdi İbrahim Pharmaceuticals

Contact PersonName : Cengiz ZaimPosition : International Markets Sales and Marketing Director Phone : +90 212 366 86 87Email : [email protected] : Resitpasa Mahallesi, Eski Buyukdere Caddesi No:4 34467 Maslak-Istanbul/Turkey www.abdiibrahim.com.tr

Brief Description of the CompanyAbdi İbrahim, Turkish pharmaceutical industry leader, was founded in 1912 in Kucukmustafapasa, Istanbul at a small pharmacy, by Pharmacist Abdi İbrahim Bey who had started the “healing” journey. Abdi İbrahim has the largest product portfolio in the sector, exceeding 180 brands and approximately 350 products by developing its own products as well as working with 30 licensors. With a powerful vision, dynamic structure and contemporary outlook, Abdi İbrahim has been the leader of Turkey’s Pharmaceutical Industry since 2003. Today, Abdi İbrahim, which operates in eight countries outside Turkey, exports to 50 countries ranging from Canada to European Union member states, from North Africa to Asia and creates the highest employment with 3,100 qualified employees in the Turkish pharmaceutical industry. The company also comes to the fore with its marketing and sales team, which is the largest in the industry. Abdi İbrahim, having the first accredited R&D center in the industry, is a role model with its technological equipment and architecture as well as R&D processes in healing the future. Owning four production facilities as AbdiBio, the biotechnological pharmaceuticals production facility that will be completed in 2017 along with its current production facilities in Kazakhstan, Algeria and Istanbul, the company is on a fast track to become a strong international player with its strategic alliances. Maintaining its leading position in the Turkish pharmaceutical industry since 2003, Abdi İbrahim increases its effectiveness in international markets with each passing day, with the aim of “becoming one of the top 100 largest pharmaceutical companies in the world” apart from being a wholly local company, as per its vision for 2020.

Production Area: 28,700 sqm

Annual Production Capacity: 350 million units

GMP Certificates: Turkey, Canada, GCC, Ukraine, Jordan FDA, Portugal (Infarmed EU), South Africa (MCC), Peru, Saudi Arabia, The United Arab Emirates

Other Certificates: ISO 14001, ISO 9001, OHSAS 18001

Occupational Health and Safety Management

Number of Employees: 3,110


Contact Person

Pantone 285 C

Adeka Pharmaceuticals

Contact PersonName : Melih GursoyPosition : General ManagerPhone : +90 212 365 08 00Email : [email protected] : Eski Buyukdere Cad. No:35 34398 Maslak-Istanbul/Turkey www.adeka.com.tr

Brief Description of the CompanySince 1956, Adeka is in the market with the aim of meeting the expectations of its stakeholders and create value for them. Adeka is an importing, distributing, manufacturing and marketing company of originator and generic products. The company markets and manufactures its own products and cooperates with trustworthy partners through exclusive license agreements.

Adeka manufactures various pharmaceutical forms particularly solids, semi-liquids, liquids and injectables.


Annual Production Capacity: Solid Products: 24 million packs, Semi-liquid Products: 7,5 million packs, Liquid Products: 8 million packs, Injectable Products: 2,4 million packs, Antiseptic Solution Products: 5 million packs

GMP Certificates: Turkey

Other Certificates: ISO 9001:2008 from TUV Rheinland

Number of Employees: 600

Ali Raif Pharmaceuticals


Brief Description of the CompanyFounded in 1928, the company was reorganized in order to trade in pharmaceuticals industry in 1963. Since 1983, the company is operating under the name of Ali Raif İlaç Sanayi A.S.

Ali Raif was marketing pharmaceuticals as a licensee of multinational companies in the early years of its foundation. Then the company became one of the leading companies of the Turkish pharmaceutical industry starting to import finished pharmaceuticals and to produce and market generic pharmaceuticals.

Ali Raif has nearly 200 pharmaceuticals with their forms in therapeutic fields such as cardiovascular, diabetics, gastrointestinal, analgesic, anti-inflammatory, anti-flu, antihistaminic and central nervous system.

With its headquarters and production facilities located in Istanbul, the company has 10 regional offices in Turkey.


Annual Production Capacity: Solid Products: 142 million packs, Liquid Products: 10 million packs


Other Certificates: OHSAS 18001, ISO 14001


Seren Ozer Business Development Manager+90 212 316 78 [email protected] Mah. Doga Sok. No:4 34418 Kagithane-lstanbul/Turkeywww.aliraif.com.tr

Contact Person

Atabay Pharmaceutical and Fine Chemicals


Brief Description of the CompanyAs one of the first (1938) pharmaceutical companies in Turkey, Atabay manufactures generic products, active pharmaceutical ingredients, veterinary and agricultural products in its facilities located in Acibadem/lstanbul and Gebze/Kocaeli. The company’s beta-lactam, veterinary, agricultural and API production plants as well as R&D laboratory are located in Gebze/Kocaeli. Atabay is the sole producer of FDA and European approved paracetamol in Europe. Atabay is planning to expand its production activities to anti-virals and MABs in the near future. The company also desires to increase its activities in regulated and emerging markets with its finished dosage forms and active pharmaceutical ingredients.

Production Area: 10,000 sqm closed area on 12,000 sqm land in Acibadem Plant,

100,000 sqm closed area on 270,000 sqm land in Gebze Plant

Annual Production Capacity: Solid Products 1 billion tablets, Semi-solid Products 10 million packs, Liquid Products 15 million packs, Injectable Products 3 million packs, Paracetamol Powder and DC Grades 4,000 tons

GMP Certificates: Turkey, USA, Ireland

Other Certificates: EDQM CoS


Bora KaymazExport Sales Manager+90 216 326 69 [email protected] Koftuncu Sok. No:1 34718Kadikoy-Istanbul/Turkeywww.atabay.com

Contact Person

PHARMACEUTICALS AND FINE CHEMICALS

Berko Pharmaceuticals


Brief Description of the CompanyFounded in 1984, Berko Pharmaceuticals established its production facility, operating on an area of 20,000 sqm, in Istanbul in 2007. With its world standard high quality manufacturing facilities, Berko produces more than 60 products including liquids, tablets, capsules, drops, pomades and sachet powders. Annual production capacity is 50 million boxes. The company’s products are pharmaceuticals, OTCs, herbal medicines, food supplements and cosmetics. Berko Pharmaceuticals has contract with 33 countries and at the moment exports its products to 18 countries.

Berko Pharmaceuticals, has FDA registration for their Manufacturing Plants to produce “food supplements” and will begin exporting to USA in 2017.


Annual Production Capacity: Syrups 18,000,000 boxes, Drops 4,800,000 boxes, Liquid Spoons 3,120,000 boxes, Tablets-Capsules 6,800,000 boxes, Cream-Pomade 9,000,000 boxes, Suppository-Ovule 3,000,000 boxes, Probiotic Capsules 2,200,000 boxes, Probiotic Liquid 770,000 boxes, Liquid Capsules 1,300,000 boxes.GMP Certificates: Turkey


S. Aykut AdalmazInternational Trade Manager+90 216 456 65 [email protected] M. Ozgur Sok. No:16-18 34779Atasehir-Istanbul/Turkeywww.berko.com.tr

Contact Person

Biem Pharmaceuticals


Brief Description of the CompanyBiem Pharmaceuticals, with headquarters in Ankara - Turkey, founded in 1989, is a privately held pharmaceutical manufacturer and distribution company focused on offering effective treatment options in Oncology, Hematology, Radiology, Ophthalmology and Transplantology fields, building proprietary portfolio of high-value branded pharmaceutical products and pursuing partnerships with other companies seeking to enter the Turkish pharmaceutical market, maximize their opportunities in territory and other selected markets. With it’s experienced export team, Biem Pharmaceuticals has already established partnerships in more than 11 countries. Registration processes of a large part of it’s portfolio are underway and expected to be completed in EU region and Canada within 2017.

Tanil TanrıkuluInternational Trade Specialist +90 312 230 29 [email protected] Reis Cad. No:21 06570 Tandogan-Ankara/Turkeywww.biemilac.com.tr

Contact Person


Contact Person

Brief Description of the CompanyFounded in 1953, Bilim Pharmaceuticals is a 100% Turkish capital owned company that manufactures and markets pharmaceuticals product. Ranking #3 among 500 corporations in the Turkish pharmaceutical sector. Bilim Pharmaceuticals consistently continues to grow at a higher rate than the market. Bilim Pharmaceuticals carries out its production activities at two separate plants. Approved by the German Ministry of Health, Bilim Cerkezkoy is one of Turkey’s most significant penicillin manufacturing facilities. Approved by the British Ministry of Health, Bilim Gebze is Turkey’s largest, most innovative and most environment-friendly drug manufacturing plant. Bilim Pharmaceuticals owns the largest R&D center of the Turkish pharmaceutical industry with a laboratory area of 4,500 sqm, where it develops new products, contributing significantly to the Turkish economy. Exporting to more than 50 countries, Bilim Pharmaceuticals has representative offices in Moldova, Bosnia& Herzegovina and Albania. Bilim Export value has reached to 50 mio USD turnover. In a sensitive sector which is directly related to human health, Bilim Pharmaceuticals prioritizes quality and adopts respect towards future generations as a corporate value.

Production Area: Cerkezkoy Plant: 9,250 sqm indoor areaGebze Plant: 51,500 sqm indoor area

Annual Production Capacity: Cerkezkoy Plant: 44 million packsGebze Plant: 250 million packs

GMP Certificates: Turkey, UK, Germany, Croatia

Other Certificates: ISO 14001, OHSAS 18001, ISO 9001EFQM Excellence Award


Gorkem DemirtenExternal Markets Director+90 212 365 17 [email protected] Mah. Zincirlikuyu Cad. No:184Beyoglu-Istanbul/Turkeywww.bilimilac.com

Bilim Pharmaceuticals


Biofarma Pharmaceuticals


Brief Description of the CompanyBiofarma, founded in 1945, is one of the oldest pharmaceutical companies of Turkey. Biofarma which was taken over by Pharmacist Mustafa Oncel in 1973 and then transferred into a limited company has always improved its facilities and specialized in the production of human drugs.

Biofarma which had moved from its first location of Mercan/Istanbul to its modern facilities of 15,000 sqm built on a total area of 17,000 sqm in Sancaktepe/Istanbul in 1990, became an incorporated company in 1998. The company is currently owned by SBK Holding


Annual Production Capacity: Tablet and film coated tablets: 1.21 billion tablets, Gelatin Capsule Products: 247,5 million tablets, Pomade and Cream: 158 tons, Soft Gelatin Capsule Products: 61,8 million tablets, Syrup and Suspension: 9 million bottles, Hormone: 111 million tablets.GMP Certificates: Turkey, UK


Md. Dr. Serhat TugrulExport Director +90 216 398 10 [email protected] Mah. Osmangazi Cad. No:156 34885Sancaktepe-Istanbul/Turkeywww.biofarma.com.tr

Contact Person


Birgi Mefar Group


Brief Description of the CompanyMefar is a contract manufacturing organization (CMO) specialized in manufacturing sterile injectables of parenteral solutions in; Ampoules, Vials, Freeze-dried products, Pre-filled syringes (PFS) and BFS (blow-fill-seal products). The company was founded in 1985 and has been serving the biggest global as well as local companies since its foundation, including exports to many EU countries. Aseptic or terminal processing methods are used for manufacturing its products. Mefar is also producing veterinary products. We have extensive experience in running method validations, method transfers and stability studies. The company also provides full service contract packaging (including Track & Trace (2D barcoding) and warehousing activities including cold chain management in accordance with GMP regulations. Mefar is certified by several European Union Health Authorities for its state-of-the-art sterile facility. Mefar’s sister-company, Birgi, is a manufacturer of empty ampoules (1-30 ml) and vials (2-30 ml) including empty lyo vials made of Type-1 glass tubings, in Turkey. It exports over 40% of its products to the EU countries.

Production Area: Mefar: 11,000 sqm - Birgi: 4,000 sqm

Annual Production Capacity: Mefar: Ampoules: Over 350 million pieces, Vials: Over 40 million pieces, BFS: Over 30 million pieces, Pre-filled Syringe: Over 120 million pieces, Freeze-dried products: 15 million pieces, Birgi: Empty ampoules: Over 400 million pieces, Vials: Over 35 million pieces.

GMP Certificates: Turkey, EMA, UK, Germany, Ukraine, Greece, Portugal, Ivory Coast, Canada

Other Certificates: ISO 9001 ‘Quality Management System’, ISO 15378, ISO 10002, ISO 14001, OHSAS 18001


Mehmet BaharogluPlanning, Logistics and Export Business Development Director+90 216 378 44 00 / [email protected] Mah. Ensar Cad. No:20 34906Kurtkoy, Pendik-Istanbul/Turkeywww.birgimefar.com

Contact Person


Centurion Pharma


Brief Description of the CompanyEstablished in 1997, Centurion Pharma is a Turkish Pharmaceutical Company dedicated to improving the quality of life for patients. Centurion Pharma is focusing on Specialist Therapeutic areas like biosimilars, vaccines, orphan drugs, plasma products and hospital generic products.

As one of the leading companies in Turkish specialty and hospital market, Centurion Pharma markets and manufactures its own developed hospital generic products such as antibiotic, antifungal, antiulcer, antipyretics, cardiovascular system and anti-osteoporotic drugs. The Company will expand its production activities to biosimilars and vaccines at the end of 2017.

The R&D acitivities are located at the Centurion production area in Ankara with a main focus on three different development areas like orphan drugs, biosimilars and hospital generics.

Production Area: 25,000 sqm (12,500 closed area)

Annual Production Capacity: Vials: 32 million packs, Freeze-dried products: 6 million packs, Pre-filled syringe/cartridge: 16 million packs.

GMP Certificates: Turkey (mid of 2017)


Dr. Alper Mengi Vice General Manager+90 212 275 07 [email protected] Sokak No:6 34349 Balmumcu Istanbul/Turkeywww.centurion.com.tr

Contact Person


Dem Pharmaceuticals


Brief Description of the CompanyDem Pharmaceuticals is a young, dynamic and fast growing pharmaceutical company. Company was established in Istanbul-Turkey in 1993. It is specialized in manufacturing of generic drugs and sales of original and generic drugs in domestic and international pharmaceutical markets. Therapeutic areas are Anti-infectives, Supportive Cancer Therapy, Immunological Treatments, Hemophilia A, Anticoagulant Treatments, Alcohol and Substance Addiction Treatment, Myeloproliferative Disease Treatment, Hormone Regulators, Anesthetic Agents, Proton Pump Inhibitors, Anti-Anemic, Calcium Salts, Phosphorus Binders, Central Nervous System, Nephrology, Physiotherapy and Respiratory Tract.

Business Development Activities: Export of pharmaceutical products, Licensing of export products, Import of pharmaceutical products, New product development, Co-development, Co-marketing.

Production Site: Dem Pharmaceuticals is using all high-tech infrastructure of Turkey’s pharmaceutical industry and works with reliable EU-GMP certificated contract manufacturers for its registered and licensed products for many years.

Certificates of GMP Compliance of Manufacturing Facilities: German Federal Ministry of Health, Greek National Organisation for Medicines, Danish Health and Medicines Authority, Ukrainian State Administration on Medicinal Products (SAUMP), Turkish Medicines and Medical Devices Agency (TMMDA)

Quality Certificates: Environmental permit from Turkey since 2014, OHSAS 18001 certification from BVQI since 2012, ISO 14001 certification from BVQI since 2012, ISO 10002 certification from BVQI since 2010, ISO 9001 certification from BVQI since 2003


Ahmet KuskonmazBusiness Development Executive+90 537 856 28 [email protected], [email protected] Mah. Kayisdagi Cad. Dem Plaza No: 172 34755 Atasehir-Istanbul/Turkeywww.demilac.com.tr

Contact Person


DEVA Holding


Brief Description of the CompanyEstablished in 1958, DEVA Holding is one of the leading pharmaceuticals companies in Turkey.

The company develops, produces, markets and sells its high-quality finished products, APIs and veterinary products worldwide. Its portfolio includes around 400 products in 13 different therapeutic areas, including oncology, hematology, ophtalmology, antibacterial, musculoskeletal, cardiovascular, gastrointestinal, respiratory, CNS and dermatology.

The company conducts its research and development activities at its dedicated R&D center which was selected as the “best R&D center” of the pharmaceutical industry in Turkey by the Ministery of Science, Industry and Technology in 2015.

As an FDA and EU GMP certified company, DEVA Holding manufactures its high quality and value added products at three manufacturing locations which are in line with domestic as well as international GMP standards.

Production Area: 67, 242 sqm closed area on 151,551 sqm land (total of three manufacturing facilities)

Annual Production Capacity: Total capacity of 515 million units Non-Sterile: Tablets, Coated tablets, Enteric-Coated Tablets, Capsules, Micropellet Capsules, Sugar Coated Pills, Syrups, Suspensions, Creams, Pomades, Ointments, Drops, Sprays, Gels, Suppositories, Soft gel capsules, MDI (metered dose inhaler), DPI (dry powder inhaler) Sterile: Ampuls, Liquid Vials, Lyophilized Vials, BFS_SVP, BFS_LVP, BFS Nebul Sterile Raw Material, Sterile and Non-Sterile Animal Health products.

Quality Certificates: Turkey, EU GMP (Germany), FDA, MCC, EDQM for API Manufacturing, Medsafe, ISO 9001:2015, EDQM

Other Certificates: ISO 14001, ISO 18001, ISO 27001

Number of Employees: 1957 (as of Feb, 8th)

Kemal CeylanogluInternational Markets Group Manager+90 212 692 92 [email protected] Merkez Mah. Basin Ekspres Cad. No:134303 Kucukcekmece-Istanbul/Turkey www.deva.com.tr

Contact Person


DrogsanPharmaceuticals


Brief Description of the CompanyDrogsan Pharmaceuticals was established in 1975 in Ankara as member of a family group which has been active in the pharmaceutical industry for 55 years. Drogsan is one of the leading pharmaceutical companies in Turkey. With its own in-house R&D, production, warehousing, distribution, sales/marketing and export facilities, Drogsan serves the world pharmaceutical industry with the goal of a healthier future. With its vision of being a research based international pharmaceutical company the mission of Drogsan is to provide healthcare professionals with innovative quality solutions prioritizing human health.

Annual Production Capacity: Solid Products: 13,2 million packs, Liquid Products: 12 million packs, Spray Products: 4,5 million packs

GMP Certificates: Turkey, GCC, Jordan, Iraq, Ethiopia, Nigeria, Ivory Coast

Other Certificates: ISO 9001:2008


Zeynep Morel KiymazBusiness Development Manager+90 312 287 74 [email protected] Mah. 1370. Sok. No:7/3 Balgat-Ankara/Turkeywww.drogsan.com

Contact Person


Eczacıbaşı Monrol Nuclear Products Co.


Brief Description of the CompanyEczacıbaşı-Monrol Nuclear Products, an equal share joint venture between Monrol Nuclear Products Inc. and Eczacıbaşı Pharmaceuticals Manufacturing that was established in 2008, leads the development of Turkey’s nuclear medicine market through the production of high-quality radiopharmaceuticals for diagnosis and treatment. Eczacıbaşı-Monrol has 13 world-class production facilities, 7 in Turkey and 4 abroad, employing modern and environment-friendly technologies. The company also has been operating cyclotrons in Kuwait, United Arab Emirates, Libya and Azerbaijan.

Eczacıbaşı-Monrol whose headquarters are located in Atasehir, has been operating with its more than 250 employees and 5 distributors to supply nuclear medicine centers in Turkey and more than 30 countries around the world with the main focus on quality and customer-oriented service.

Production Area: 7 production plants in Turkey with each of them around 1,000 sqm

GMP Certificates: Gebze, Turkey

Other Certificates: ISO 9001, ISO 14001, OHSAS 18001, ISO13485


Arda KaradumanInternational Sales Manager+90 216 544 05 44 [email protected] Mah. Sutcuyolu Cad. No:72/A34746 Atasehir-Istanbul/Turkeywww.monrol.com

Contact Person


Contact Person

Farma-Tek Pharmaceuticals


Brief Description of the CompanyFarma-Tek Pharmaceuticals is a privately owned pharmaceutical company, founded in 1991. Farma-Tek is an experienced pharmaceutical company in distributing, marketing and manufacturing specialty products in a wide range of therapeutic areas including dermatology, nephrology, CVS, CNS, urology and hematology.

The company’s headquarter is in Istanbul-Turkey with a professional sales force in the territory of Turkish Republic. Starting from 2017 Farma-Tek is conducting pharmaceutical production and R&D activities in company’s own manufacturing site located in Kirklareli. The company’s production capacity includes solid, semi-solid and liquid (dermal solution) forms.

The company is being transformed into a state of the art manufacturing and research company to work by finding effective, more affordable treatments to integrate our information&experience and enhance our insight to help patients’ health. For this reason it offers its partners finished product supply, tech transfer, R&D activities and contract manufacturing.



Other Certificates: ISO 9001


Hakan YildirimCEO+90 216 314 23 [email protected] Mah. Bayraktar Bulvari Beyan Sok. No:12 34775 Umraniye-Istanbul/Turkeywww.farma-tek.com

Contact Person


Contact Person

İLKOPharmaceuticals


Brief Description of the Company: The current representative of more than 50 years experience in the Turkish pharmaceutical industry, İLKO Pharmaceuticals continues its efforts to increase the standards of living in Turkey and in the world with vanguard and innovative approaches based on its past experiences. The roots of İLKO İlaç San ve Tic. A.Ş. are based on the drugstore pharmacology of the late Mr. Mustafa Öncel - one of the second generation pharmacists of Turkey - that started with magistral drug production in the 1960s and his investments in the pharmaceuticals industry. Based on the principle that the most important two factors for effectiveness in the pharmaceutical industry are R&D and production means, İLKO Pharmaceuticals established ‘İLKO Research and Development Center’ in 2009 in Hacettepe University Techno City, and the company also opened ‘İLKO Pharmaceutical Production Plants’ in 2012 in Konya 3rd Organized Industry Zone to start its operations in the pharmaceutical industry. İLKO Pharmaceuticals Production Plants is the biggest pharmaceutical industry investment realized in Anatolia so far. In 2014, ILKO Pharmaceutical Production Plants received confirmation of conformity to the European GMP (Good Manufacturing Practices) from the MHRA (Medicines and Healthcare Products Regulatory Agency of the UK). With this MHRA approval, ILKO Pharmaceuticals continues to get licenses in and export products to 25 countries located in different regions. İLKO Pharmaceuticals broke ground in Turkey in December 2013 and took a step to make Turkey a player of the biotechnology market, shown as the future of the global pharmaceutical industry, by founding ILKOGEN with the partnership of South Korean biotechnology company Genexine. ILKOGEN is the first biotechnological pharmaceutical research & development, production and international marketing investment of Turkey. Furthermore, within the framework of the new attempts of İLKO Pharmaceuticals in the field of biotechnology, İLKO ARGEM Biotechnology Center was established in Istanbul Teknopark towards the end of 2014.

Production Area: 25,000 sqm closed area on 250,000 sqm land

Annual Production Capacity: The capacity of the plant has been planned for 120 million units per year on one shift, Current capacity is 25 million packs on one shift

GMP Certificates: Turkey, UK MHRA, KMCA Iraq, Uganda

Other Certificates: ISO 14001, OHSAS 18001, Medical Devices Quality Management System ISO 13485


Cafer KececiogluExport Manager+90 216 564 80 00 [email protected] Karani Mah. Colakoglu Sk. No:10 Kat: 7-8-9 34885Sancaktepe-Istanbul/Turkeywww.ilko.com.tr

Contact Person


Contact Person

Keymen Pharmaceuticals


e em

Brief Description of the CompanyKeymen Pharmaceuticals, established in 1973, is a medium sized, family owned pharmaceutical company, based in Turkey, which commercialises childhood & adult vaccines, antisera and medicines. Keymen Pharmaceuticals represent well known vaccines manufacturers from India, Indonesia and China.

Keymen Pharmaceuticals offers out-licensing of generic parenteral drugs and food supplements. Currently Keymen Pharmaceuticals exports generic parenteral drugs and food supplements to Azerbaijan, Georgia and T.R. Northern Cyprus.

Keymen Pharmaceuticals has signed Global Compact agreement in 2010 and follows its operations under the principles of reliability, transparency and accountability.


Dr.O.Mutlu TopalCoordinator+90 312 485 37 [email protected] Mah. 1480. Sok. No:2 B Blok B50-B51 06510 Cankaya-Ankara/Turkeywww.keymen.com.tr

Contact Person


Contact Person

KurtsanPharmaceuticals


Brief Description of the CompanyKurtsan Pharmaceuticals has been active in the fields of herbal throat pastilles, dermatological and respiratory tract pharmaceuticals, medical plasters and natural body care cosmetics since 1955. The group reaches all around Turkey and exports to more than twenty different countries. The company also gives R&D services for developing new formula and private label production.



Other Certificates: ISO 22000, ISO 13485, ISO 9001, CE


Ayse Borce SongucExport Manager+90 212 481 30 [email protected] Otomarket A2 Blok Burak Plaza 734218 Bagcilar-Istanbul/Turkeywww.kurtsanexport.com

Contact Person


Contact Person

NobelPharmaceuticals


Brief Description of the Company: Nobel İlaç has been active in the international market with a national capital from 1964 until today and develops pioneer and novelist products which increases the life quality by using the resources productively with the principle of being a worldwide trustworthy organization. Nobel İlaç has been listed among the fastest growing 100 companies and holds the leadership in exportation among the Turkish medicinal firms. Such success of Nobel İlaç is based on product development, manufacturing and sales-marketing strategy conducted in Turkey and in the world.Nobel İlaç in Turkey and in the world: The headquarters of Nobel İlaç holding is in Umraniye. Research and development activities are conducted in the manufacturing site and R&D center in Duzce. Drug raw material and micro pellet manufacturing is conducted In Ulkar Kimya in Cerkezkoy. Besides the manufacturing sites in Turkey, Nobel İlaç has two more manufacturing sites in Kazakhstan and Uzbekistan. The world standard products manufactured in these facilities are presented to the surrounding countries. The facility located in Kazakhstan is the largest of the Central Asia and is the first drug manufacturing facility receiving GMP in Kazakhstan.Product portfolio is as below: From 1964 until today, Nobel İlaç has provided quality and affordable drug alternatives to the Turkish people and to the world, which is still active inside and outside the country with almost 100 products.Such products can be grouped as follows: Painkillers and rheumatism drugs, Antibiotics and fungicides, Cold drugs, Digestion system drugs, Urinary system drugs, Cardiovascular system drugs, Central nervous system drugs, Supplementary nutrients such as probiotics, fish oils, Vitamins and mineral supplements for empowering the immune system, products for bone joints and cartilage health, hair-nail and skin health products, cosmetics, personal hygiene and care products.

Production Area: 63,000 sqm closed area

Annual Production Capacity: Solid Products: 102 million packs, Semi-solid Products: 3 million packs, Liquid Products: 16 million packs, Injectable Products: 15 million packs

GMP Certificates: Turkey, Germany, Ukraine, Bulgaria,

Other Certificates: ISO-9001:2008, ISO-14001:2004 by the TÜV CERT


Muhip AsutayStrategic Portfolio Manager+90 216 633 60 [email protected] Mah. Dr. Adnan Buyukdeniz Cad. No: 14 34768 Umraniye-Istanbul/Turkeywww.nobel.com.tr

Contact Person


Contact Person

Oro Pharmaceuticals

Brief Description of the CompanyOro Pharmaceuticals, which started its business in the Turkish Drug Market in 1969 with its foundation by three valuable old pharmacists, is one of the most rooted and oldest companies in the sector. The company business started to develop rapidly with the change in the corporation structure in 2002. Oro Pharmaceuticals has gained a serious acceleration and development since 2006 to the present time (especially with the reorganization which was realized between 2002 and 2006). Oro Pharmaceuticals has adapted the motto “time is money” by realizing the principles of rapid decisions and applications with its property of being a family company. Currently, Oro Pharmaceuticals is in the position of being a leader company which grows rapidly. It operates in all the areas including human medicinal products, which include medicinal products, food supplements, dermocosmetic products and medical devices. Marketing of medicinal products in pharmacies is among the main principles of the company. Oro Pharmaceuticals has a growth course above the average annual market growth figures in the Turkish drug market. Its products are found on the shelves of almost all of the 24,300 pharmacies found in the market.

Annual Production Capacity: 6 million boxes (planned)

Other Certificates: ISO 9001-2008 ISO 9001-13485 CE


R. Berk TurkerVice General Manager+90 216 661 37 [email protected] Sinan Mah. Yedpa Ticaret Merkezi H-2 Cad. No: 177-178Atasehir-Istanbul/Turkeywww.oroilaclari.com


Contact Person

Pharmactive

Brief Description of the CompanyPharmactive is Turkey’s brand new pharmaceutical company with the largest manufacturing facility in the country. The company was founded by the former co-owners of Hedef Alliance and aims to position itself within top 5 generic firms in Turkey thanks to its wide range of products in 10 different therapeutic areas. Pharmactive aims to create 25% of its sales from international business. We are open to discuss providing contract manufacturing services, co or full product development services, co-marketing and any other type of licensing agreements.

Production Area: 45,000 sqm in operation (80,000 sqm upon completion of phase 2)

Annual Production Capacity: Total capacity of 330 million units (Tablet and Film-Enteric-Sugar Coated Tablets, Effervescent Tablet, Sachet, Dry Powder for Suspension, Hard Gelatin Capsule, Pomade, Cream, Gel, Syrup, Suspension, Mouth and Nasal Spray, Oral Solutions, Eye and Ear drops)

GMP Certificates: Turkey, Germany

Other Certificates: ISO 14001, ISO 18001, OHSAS 18001


Yunus SancakCMO & Strategy Planning Manager+90 212 604 55 00 [email protected] Mah. Dilmenler Cad. Aslanoba Plaza No:19/334218 Bagcilar-Istanbul/Turkeywww.pharmactive.com.tr


Contact Person

Polifarma Pharmaceuticals

Brief Description of the CompanyFounded in 1986 in Istanbul, Polifarma Pharmaceuticals is active in IV fluids (serum) production over 30 years. By March 2011, Polifarma carried out its manufacturing activities in Corlu/Ergene facility with an investment of $ 50 million. Polifarma’s state of art parenteral solution production facility uses advanced technological equipment and operates in compliance with the norms of current Good Manufacturing Practices (c-GMP). Polifarma offers extensive form and volume alternatives in the production of large volume parenterals. While focusing product range by several packaging alternatives in LVP, Polifarma widen the product range with vials, lyophilized powders and prefilled syringes in SVP. By April 2016 Polifarma started manufacturing in its own aseptic line. The company aims to become a global leader in the field of parenteral solution, and is continuously enlarging networks at international markets.


Annual Production Capacity: PVC (Polyvinyl Chloride): 80,000,000 bags, PP (Polypropylene): 40,000,000 bags, Vacuumed Glass Bottle: 8,000,000 units, PP (Polypropylene):6,000,000 bottles


Other Certificates: ISO 9001, ISO 13485, ISO 14001, OHSAS 18001


Servet AksuInternational Operations Director+90 533 582 45 [email protected] Tower Halkali Merkez Mah. Basin Ekspres Yolu No: 9 K: 6 Halkali-Istanbul/Turkeywww.polifarma.com.tr


Contact Person

Recordati Pharmaceuticals

Brief Description of the CompanyRecordati Pharmaceuticals is a subsidiary of Recordati S.p.A. Recordati, established in 1926, is a European pharmaceutical group, listed on the Italian Stock Exchange, with a total staff of 4,000 dedicated to research, development, manufacturing and marketing of pharmaceuticals. It has headquarters in Milan (Italy), operations in main European countries and a growing presence in the new markets of Central and Eastern Europe. Recordati is committed to research and development of new drug entities especially within the cardiovascular, urogenital therapeutic areas and of treatments for rare diseases.

Recordati promotes a wide range of pharmaceuticals in various therapeutic areas.

Production Area: 4.791 sqm

Annual Production Capacity: Solid Products: 40 million packs, Semi-solid Products: 15 million packs, Liquid Products: 15 million packs, Effervescent Granule Products: 2 million packs



Tansun UzunogluExport and Business Development Manager90 212 401 91 00 Ext: [email protected] Mah. Sumer Sok. Maslak Office Building No: 4 K: 6 Maslak-Istanbul/Turkeywww.recordati.com.tr


Contact Person

Sandoz Turkey

Nilufer GurpinarCluster Head of Turkey & Middle East Communications+90 216 570 96 [email protected]&Akel Is Merkezi, Ruzgarlibahce Mah. Sinan Eroglu Cad. No: 6 34805 Kavacik Beykoz-Istanbul/Turkey www.sandoz.com.tr

Brief Description of the CompanySandoz is a global leader in generic and biosimilar pharmaceuticals. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people’s lives. We contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine.

Our portfolio of approximately 1000 molecules, covering all major therapeutic areas, accounted for 2015 sales of USD 10,1 billion. In 2015, our products reached more than 500 million patients and we aspire to reach one billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.

Sandoz is a reliable brand in Turkey with a strong heritage dating back to the 1950’s. Sandoz has 2 FDF sites in Gebze and 1 API located in Tuzla. Sandoz Turkey is also listed amongst the top exporter in pharmaceutical products since 2005, exporting medicines to 30 countries as well as offering its products for the service of approximately 60 countries. Sandoz’s Gebze plant is ranked first among exporters with an amount of USD 59 million.


Annual Production Capacity: Solid Products: 4,5 billion solids, Semi-solid Products: 10 million packs, Liquid Products: 11 million bottles, Powder suspension: 3,7 million packs

GMP Certificates: Turkey, Germany



Contact Person

Sandoz Syntek Active Pharmaceutical Ingredients

Nilufer GurpinarCluster Head of Turkey & Middle East Communications+90 216 570 96 [email protected] Deri Organize Sanayi Bolgesi 1. YolH-8 Parsel, Tuzla-Istanbul/Turkeywww.sandoz.com.tr

Brief Description of the CompanyThe company produces APIs since 1972 in accordance with CGMP, DMF and EU COS rules.

The company’s product range includes Omeprazole, Omeprazole Mg., Pantoprazole Na, Rabeprazole Na, Sertraline HCl, Mephenoxalone, Oxolamine Citrate, Naftifin HCl, Pregabalin, Esomeprazole Mg and Tadalafil Absorbate


Annual Production Capacity: Solid Products: 1,000 tons

GMP Certificates: Turkey, Australia, Slovenia


Sanovel Pharmaceuticals


Brief Description of the CompanySanovel, a 100% Turkish capitalized company, operates in the pharmaceutical industry for over 30 years, and has created a distinguished name for having a dynamic and innovative structure.

Sanovel has 2500 employees with having one of the largest sales&marketing team in Turkey. As of 2016, the company has growth 3 times higher than the total market also by adding a considerable number of first to market generics to its portfolio for 2017.

Closely following the developments in the world, Sanovel is the leading company in Turkey on investing and developing value added branded generics, high technology products and also device included respiratory products. As a result of these investments, Sanovel accomplished to be the first Turkish firm to ever have an approved patent from the American Patent Office. Sanovel has earned the right to preserve the American patents of the four medical formulations until 2033.

Sanovel has an EU GMP approved facility with a 60,000 sqm and capable of manufacturing all pharmaceutical dosage forms. Sanovel has 148 branded generics in its portfolio and exist in both local and international markets with this large protfolio. Export operations have started in 2005 and ongoing with a significant growth every year. Spain, Russia, Ukraine, CIS, Balkan States, LATAM, South Asia, South Africa and MENA are some of the regions that Sanovel has either strong partnerships or its own sales&marketing teams.

With the goal of existence in all international markets, Sanovel will penetrate to US market in 2018 with a strong portfolio.


Annual Production Capacity: 300 million boxes

GMP Certificates: Turkey, Germany, Spain, Ukraine, GCC, Russia

Other Certificates: ISO 14001, OHSAS 18001, Occupational Health and Safety Management

Number of Employees: Nearly 2500

Melda MisirliGroup Business Development Manager+90 212 362 12 [email protected]; [email protected] cad. No: 14 34460 Istinye Sariyer-Istanbul/Turkeywww.sanovel.com.tr

Contact Person


Serdar GamberExport Manager+90 212 220 64 [email protected] Okmeydani, Boru Cicegi Sok. No:16 34382 Sisli – Istanbul/Turkeywww.santafarma.com

Contact Person

Brief Description of the CompanySanta Farma entered the pharmaceutical market in 1944. In 1954 it signed its first license agreement and soon became a major local producer and distributor for European and US companies in Turkey. In 1982, it adopted GMP standards. In 2012, it was granted an EU-GMP from Austria and also received the prestigious “Pharmaceutical Industry Golden Mortar Achievement” award in Turkey.

In these 70+ years, Santa Farma has undergone significant changes but its mission has always been to provide an outstanding service to its customers and adhere to its core values that focus on respect for the individual, the workplace and society at large.

In 2015, it inaugurated its brand-new production site, with a capacity of 150 million boxes and an ultra-modern R&D facility, where it will continue developing best-in-class medicines. This facility has been granted an EU-GMP from Croatia.

Besides being a leading company in Turkey with both licensed proprietary medicines and its own generics, Santa Farma also markets its products in several CIS, Middle East, S.E. Asian and Balkan countries.

Production Plant and R&D Center Total Area: 80,085 sqm

Closed Area: 44,046 sqm

Annual Production Capacity: 150 million packs/per year

GMP Certificates: Turkey, Croatia (EU)


Santa Farma Pharmaceuticals

Vem Pharmaceuticals


Taha IpekExport Responsible+90 212 347 75 [email protected] Cad. Yesilyurt Sk. No:3/2, Cankaya-Ankara/Turkeywww.vemilac.com

Contact Person

Brief Description of the CompanyEstablished in Ankara in 2000, Vem is one of the foremost Turkish pharmaceutical company that offers variety of pharmaceutical finished products in various forms ( vial, ampoule, lyophilization, bottle, tube, tablet, capsule, BFS nebule, prefilled syringe ) for different treatment areas such as intensive care, general anesthesia, local anesthesia, cardiovascular and andrologia.

Vem manufacturing site is located at Cerkezkoy Organized Industrial Zone within total of 21,000 m² field which has a 20,000 m² modern indoor area with ongoing expansions and diversifications.

Production site uses state of the art technology and latest developments in pharmaceutical manufacturing and designed in accordance with cGMP (Good Manufacturing Practices

Production Area: Solid, Semi solid, Injectables (ampoules, vials and lyophilizations), prefilled syringe, BFS nebules are manufactured at Cerkezkoy plant.

Annual Production Capacity: Cerkezkoy Plant: 75 million boxes


Other Certificates: ISO 13485, ISO 9001


World Medicine Pharmaceuticals


Murat YesilBusiness Development Director+90 212 474 70 [email protected] Mah. Camiyolu Cad. WM Plaza No:50 Bagcilar-Istanbul/Turkey www.worldmedicine.com.tr

Contact Person

Brief Description of the CompanyWorld Medicine Pharmaceuticals Turkey activities started in the year of 2011 being affiliated to the World Medicine Worldwide Corporate Group. World Medicine has the aim to be a company presenting the effective medicines which are in the high quality standard and increasing the quality of life in the field of health in which we have activities. Being a reliable partner, supplier and employer, it gives the greatest priority to the professionalism in all the spheres of its activity. For this, World Medicine develops and manufactures medicines of various therapeutic categories. It is proud to mention that up-to-date R&D laboratory pf the company is one of the best laboratories of the Eastern Europe. The factory owned by the company produces various products of different pharmaceutical forms: film-coated and enteric-coated tablets, soft and hard gelatin capsules, sachets, dry powders for suspension preparation, oral solutions, nasal sprays, eye and ear drops, inhalation aerosols, micro-dose capsule anti-asthmatic medicines, granules, and syrups. World Medicine product portfolio is included more than 350 products. World Medicine covers all around the world and exporting products more than 35 countries. Its administrative office, R&D laboratory and production facility covering total area of more than 10,000 m2 are located in Istanbul. All production processes are in a strict conformity with the US and European standards and are certified by the related institutions. Its logistics center has been built on an area of 6,600 m2 according to the world standards it has the capacity of 20,000 palettes.


Annual Production Capacity: Film-coated and enteric-coated tablets: 900 million tablets, Soft gelatin capsules: 900 million capsules, Hard gelatin capsules: 450 million capsules, Micro dose capsule antiasthma drugs: 240 million capsules, Dry powder for suspension/Granules: 12 million bottles, Eye&Ear drops/Nasal spray: 24 million bottles, Inhalation aerosol: 6 million containers, Sachet: 54 million sachets

GMP Certificates: Turkey, EU, Russia, Ukraine, Saudi Arabia, Ivory Coast, Ethiopia, Philippines, Thailand, Sudan, Belarus, Kyrgyzstan, Cambodia

Other Certificates: ISO-9001:2008, ISO-14001:2004



Selim TarraganoIndustrial Pharmaceuticals Sales, Group Manager +90 212 339 10 [email protected] Cad. No:193 34394 Levent-Istanbul/Turkeywww.zentiva.com.tr

Contact Person

Brief Description of the CompanyZentiva is one of the first pharmaceuticals production facilities in Turkey. The company was established in 1952 in Istanbul and moved to its modern state-of-the-art facilities at Luleburgaz (150 km to Istanbul) in 1992. The total capacity of 425 million packs per year almost in all pharmadceutical forms makes Zentiva one of the largest producers of pharmaceuticals by volume, not only in Turkey but also in Europe.

Zentiva is a Sanofi company who is a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs.

Production Area: 67,000 sqm closed area on 338,000 sqm land

Annual Production Capacity: Solid Products: 155 million packs, Semi-solid Products: 55 million packs, Liquid Products: 90 million packs, Injectable Products: 30 million packs, Non-Sterile Cephalosporin Products: 20 million packs, Sterile Cephalosporin Products: 50 million units, Penicillins Products: 25 million packs,

GMP Certificates: Turkey, EU (UK, Germany, Czech, Slovakia, Denmark, Sweden, Romania), GCC, Australia, Brazil, Japan, Taiwan, Ukraine, Belarus, South Africa, Russia

Other Certificates: ISO 9001, ISO 27001, ISO 14000, OHSAS 18001


Zentiva Healthcare Products

Notes:

www.trpharmaexporters.org.tr | www.ieis.org.tr

Contact information:

+90 212 353 11 20 Fax: +90 212 353 11 41 [email protected]

Pharmaceutical Manufacturers Association of Turkey (IEIS)

| · Email [email protected] Adress : Resitpasa Mahallesi, Eski Buyukdere Caddesi No:4 34467...

Documents

Transcript of | · Email [email protected] Adress : Resitpasa Mahallesi, Eski Buyukdere Caddesi No:4 34467...